Please login to the form below

Not currently logged in
Email:
Password:

oncology

This page shows the latest oncology news and features for those working in and with pharma, biotech and healthcare.

A look ahead to key trial readouts at ESMO

A look ahead to key trial readouts at ESMO

The countdown to Europe’s premier oncology conference ESMO has begun, and once again it promises to deliver an astonishing array of new studies with the potential to move cancer treatment ... forward. There will be the usual crop of new studies for

Latest news

More from news
Approximately 392 fully matching, plus 1,107 partially matching documents found.

Latest Intelligence

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    MRC scientists are welcome to work in the building and our oncology staff are working in the CRUK Institute. ... revenues in its oncology division grew by 42% in the first half of this year, with chief executive Pascal Soriot claiming the company was

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    He says the company is “very confident”of sustaining growth in China, and says its broad portfolio of medicines across oncology, respiratory and cardiovascular, metabolic and renal will help it achieve ... In June, AstraZeneca’s oncology sales

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    In terms of the industry as a whole. our aspirations are to be a global oncology leader – full stop, ”John Oyler told the Goldman Sachs health conference in June. ... Nevertheless, Oyler observes that the sheer size of China means that there will be

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    Making the PRIME grade. Just over half of requests that were granted for PRIME by March 2018 are for treatments in oncology and haematology-haemostaseology (figure 1).

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Following after the first generation of mainly antibody-based immuno-oncology drugs are a host of small-molecule drugs. ... also extending to targeted cancer drugs, with Loxo Oncology and Bayer’s larotrectinib filed for TRK gene fusion tumours and due

More from intelligence
Approximately 17 fully matching, plus 170 partially matching documents found.

Latest appointments

More from appointments
Approximately 12 fully matching, plus 259 partially matching documents found.

Latest from PMHub

  • The dark side of direct-to-consumer genetic tests

    The dark side of direct-to-consumer genetic tests. Direct-to-consumer testing is an affordable way to better understand your DNA, but is this a leap forward in innovation or another layer clouding an already complex market? From anxious patients to

  • Genetic counsellors: the new healthcare influencers?

    Genetic counsellors: the new healthcare influencers? Blue Latitude Health explores the relationship between physicians and genetic counsellors, and the impact this has on turning precision medicine into a reality for oncology ... During a recent pilot of

  • Unlocking potential: How can pharma capitalise on its resources to support the NHS?

    For example, one company is engaging with an audience of oncology specialists across the network to raise awareness of a specific gene test that can be performed to identify at risk

  • PRMA Consulting Ltd

    Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,

  • Mastering the precision medicine opportunity

    During the last few years, we have started to see a movement towards a new molecular taxonomy of oncology, which defines a tumour by its oncogenic drivers and matches treatment accordingly.

More from PMHub
Approximately 46 fully matching, plus 96 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics